STOCK TITAN

Jennifer Michaelson proposes sale of 8,000 shares (CGEM)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Jennifer Michaelson proposes sale of 8,000 common shares. The filing lists 8,000 shares to be sold on 02/20/2026 via an exercise of stock options with cash consideration. The record also lists prior 10b5-1 sales totaling multiple transactions in 20252026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for CGEM report?

The filing reports a proposed sale of 8,000 common shares on 02/20/2026 by exercise of stock options, listing cash as the consideration. It also documents prior 10b5-1 sales by Jennifer Michaelson in 20252026.

Who is named in the Form 144 and what broker is listed?

The filing names Jennifer Michaelson as the reporting person and lists Morgan Stanley Smith Barney LLC as the broker. The broker’s address and a NASDAQ listing are shown alongside the proposed 8,000-share sale on 02/20/2026.

What prior transactions are disclosed in the Form 144?

The filing discloses multiple prior 10b5-1 sales by Jennifer Michaelson, including transactions of 4,000 shares on 01/22/2026 and 4,000 on 11/24/2025, plus smaller sales in 12/2025 and 02/12/2026, with listed dollar amounts.

How is the proposed sale being effected and what proceeds type is shown?

The proposed 8,000-share sale is shown as an exercise of stock options and the filing lists cash as the method of consideration. The entry associates the sale with the issuer and a transaction date of 02/20/2026.
Cullinan Oncology Inc

NASDAQ:CGEM

CGEM Rankings

CGEM Latest News

CGEM Latest SEC Filings

CGEM Stock Data

819.98M
56.27M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
CAMBRIDGE